Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Insulin-like growth factor 1 receptor | ||
| Ligand | BDBM50336319 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_716595 (CHEMBL1670374) | ||
| IC50 | 285±n/a nM | ||
| Citation |  Jin, M; Kleinberg, A; Cooke, A; Gokhale, PC; Foreman, K; Dong, H; Siu, KW; Bittner, MA; Mulvihill, KM; Yao, Y; Landfair, D; O'Connor, M; Mak, G; Pachter, JA; Wild, R; Rosenfeld-Franklin, M; Ji, Q; Mulvihill, MJ Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacy. Bioorg Med Chem Lett21:1176-80 (2011) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Insulin-like growth factor 1 receptor | |||
| Name: | Insulin-like growth factor 1 receptor | ||
| Synonyms: | CD_antigen=CD221 | IGF-I receptor | IGF1R | IGF1R_HUMAN | Insulin-like growth factor 1 receptor (IGF1R) | Insulin-like growth factor 1 receptor (IGFIR) | Insulin-like growth factor 1 receptor alpha chain | Insulin-like growth factor 1 receptor beta chain | Insulin-like growth factor I receptor | Insulin-like growth factor receptor (IGFR) | ||
| Type: | Protein | ||
| Mol. Mass.: | 154776.79 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P08069 | ||
| Residue: | 1367 | ||
| Sequence: |
| ||
| BDBM50336319 | |||
| n/a | |||
| Name | BDBM50336319 | ||
| Synonyms: | CHEMBL1667937 | trans-4-(8-amino-1-(8-fluoro-2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)cyclohexanecarboxylic acid | ||
| Type | Small organic molecule | ||
| Emp. Form. | C28H24FN5O2 | ||
| Mol. Mass. | 481.5209 | ||
| SMILES | Nc1nccn2c(nc(-c3ccc4ccc(nc4c3F)-c3ccccc3)c12)[C@H]1CC[C@@H](CC1)C(O)=O |r,wU:27.31,wD:30.38,(18.25,-15.15,;18.26,-16.69,;16.93,-17.46,;16.93,-19.01,;18.26,-19.78,;19.6,-19,;21.07,-19.47,;21.97,-18.21,;21.06,-16.97,;21.83,-15.64,;21.06,-14.32,;21.82,-12.98,;23.37,-12.98,;24.13,-11.66,;25.66,-11.65,;26.44,-12.99,;25.67,-14.31,;24.14,-14.31,;23.37,-15.65,;24.14,-16.98,;27.97,-12.99,;28.74,-14.32,;30.28,-14.32,;31.05,-12.99,;30.27,-11.65,;28.73,-11.66,;19.59,-17.45,;21.56,-20.93,;23.06,-21.23,;23.54,-22.7,;22.51,-23.84,;21.01,-23.53,;20.53,-22.07,;22.99,-25.31,;24.5,-25.63,;21.97,-26.45,)| | ||
| Structure | 
| ||